Home / Recalls / Apotex Corp. / D-0122-2024

D-0122-2024 Class II Ongoing

Recalled by Apotex Corp. — Weston, FL

FDA drug recall D-0122-2024 was initiated by Apotex Corp. on Nov 1, 2023 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine The recall status is ongoing. Affected quantity: 4,074.

Recall details

Product Type: Drugs
Report Date: Dec 6, 2023
Initiation Date: Nov 1, 2023
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 4,074

Product description

Paroxetine Hydrochloride Tablets USP, RX only, 40 mg, 1000-count bottle, NDC#:60505-0101-4 Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326.

Reason for recall

Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

Distribution pattern

Nationwide

Code information

Lot numbers: RV0131, RV2387, RV2389, RW3296, RV2388; Exp. 08/2024

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0122-2024
openFDA file date: Nov 10, 2026
Loaded by RegDataLab: Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by Apotex Corp.

D-0877-2026 Class II — Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only… (Sep 23, 2026)
D-0804-2026 Class II — Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx… (Aug 13, 2026)
D-0510-2026 Class II — Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only… (Apr 8, 2026)
D-0407-2026 Class II — Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx… (Mar 5, 2026)
D-0676-2025 Class II — Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and… (Sep 5, 2025)
D-0677-2025 Class II — Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile… (Sep 5, 2025)
D-0496-2025 Class II — Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, 15 mL, Rx… (May 28, 2025)
D-0495-2025 Class II — Azelastine HCl Ophthalmic Solution, USP, 0.05%, 6 mL, Rx Only, Sterile, Mfg. by… (May 28, 2025)
D-0494-2025 Class II — Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured… (May 28, 2025)
D-0457-2025 Class II — Lacosamide Oral Solution, USP, 10 mg/mL, 200 mL, Rx Only, Manufactured by… (May 28, 2025)